XEVUDY 500mg concentrate for solution for infusion GLAXO SMITH KLINE ORIGINAL MEDICINE
Chemical substance: sotrovimab
ATC code: J06BD05 • Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies
Active substance
Results for the substance sotrovimab
1 result
About this active substance
Sotrovimab is a monoclonal antibody used for the treatment of SARS-CoV-2 (COVID-19) infection in patients at high risk of developing severe disease. It works by binding to the spike protein of the virus, preventing it from entering human cells.
The medication is administered intravenously, as directed by a doctor, usually as a single dose. It is important for patients to be monitored during administration to prevent adverse reactions.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fever, and nausea. In rare cases, severe reactions such as anaphylactic reactions may occur. Patients should be informed of these risks before administration.
The medication is administered intravenously, as directed by a doctor, usually as a single dose. It is important for patients to be monitored during administration to prevent adverse reactions.
Patients should be aware of potential side effects, such as injection site reactions, fever, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, fever, and nausea. In rare cases, severe reactions such as anaphylactic reactions may occur. Patients should be informed of these risks before administration.